Treatment of GERD: Promotility agents

Practical Gastroenterology

Volumn 24, Issue 9, 2000, Pages 52-66

  Fisher, R S ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ATROPINE; BACLOFEN; BETHANECHOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; CISAPRIDE; DOMPERIDONE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; ERYTHROMYCIN; LOXIGLUMIDE; METOCLOPRAMIDE; MORPHINE; MOTILIN; N(G) METHYLARGININE; NORCISAPRIDE; PRUCALOPRIDE; SEROTONIN 4 AGONIST; TEGASEROD; TRIMEBUTINE; UNCLASSIFIED DRUG;

BRONCHUS MUSCLE; ESOPHAGUS MOTILITY; ESOPHAGUS MUCOSA; ESOPHAGUS STRICTURE; GASTROESOPHAGEAL REFLUX; HEART MUSCLE; HOSPITAL PERSONNEL; HUMAN; LOWER ESOPHAGUS SPHINCTER; MUSCLE REFLEX; OROPHARYNX; PREVALENCE; REVIEW; SALIVARY GLAND; STOMACH CONTENT; SYMPTOMATOLOGY; TRACHEOBRONCHIAL TREE; UNITED KINGDOM; UNITED STATES;

EID: 0033803826     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Symptomatic gastroesophageal reflux: Incidence and precipitating factors
2. Dyspepsia in England and Scotland
3. Twenty-four hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux
4. The gastroesophageal sphincter in healthy human beings
5. Lower esophageal sphincter pressure as an index of gastroesophageal reflux
6. Does hiatus hernia affect competence of the esophageal sphincter?
7. Mechanisms of lower esophageal sphincter incompetence in patients with symptomatic gastroesophageal reflux
8. Transient lower esophageal sphincter relaxation
9. Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis
10. Effect of the diaphragmatic contraction on lower esophageal sphincter pressure in man
11. Identification and mechanism of delayed esophageal acid clearance in subjects with hiatal hernia
12. Determinants of gastroesophageal junction incompetence, hiatal hernia, lower esophageal sphincter or both?
13. Sphincterlike thoracoabdominal high pressure zone after esophago-gastrectomy
14. Esophageal peristaltic dysfunction in peptic esophagitis
15. The oesophageal motor response to reflux is not impaired in reflux oesophagitis
16. Cholinergic effects on esophageal transit and clearance
17. Relations among autonomic nerve dysfunction, oesophageal motility and gastric emptying in gastro-oesophageal reflux disease
18. Effect of sleep on swallowing, esophageal peristalsis and acid clearance
19. Clearance of spontaneous gastroesophageal reflux in awake and sleeping infants
20. Effect of esophageal emptying and saliva on clearance of acid from the esophagus
21. Oesophageal clearance of small amounts of equal or less than one milliliter of acid
22. Salivary secretions in reflux esophagitis
23. Gastric emptying in patients with gastroesophageal reflux
24. Gastric distention: A mechanism for postprandial gastro-esophageal reflux
25. Gastric emptying of solid food in patients with gastroesophageal reflux
26. Alkaline esophagitis: A comparison of the ability of components of the gastroduodenal contents to injure the rabbit esophagus
27. Do bile acids reflux into the esophagus? A study of normal subjects and patients with gastroesophageal reflux disease
28. Role of acid and duodeno-gastroesophageal reflux in gastroesophageal reflux disease
29. Role of acid and duodenogastric reflux in esophageal injury: A review of animal and human studies
30. Stimulation of the incompetent lower esophageal sphincter. A possible advance in therapy of heartburn
31. Effects of cholinergic stimulation on human esophageal peristalsis
32. Cholinergic therapy of chronic heartburn. A controlled trial
33. Reflux esophagitis. Effect of oral bethanechol on symptoms and endoscopic findings
34. The effect of oral and intravenous metoclopramide on human lower esophageal sphincter pressure
35. Action of oral metoclopramide on the gastroesophageal junction of man
36. Comparative effects of metoclopramide and bethanechol on lower esophageal sphincter pressure in reflux patients
37. Effect of metoclopramide on guinea pig stomach: Critical dependence on intrinsic stores of acetylcholine
38. Metoclopramide: Pharmacology and clinical application
39. Effect of metoclopramide on normal and delayed gastric emptying in gastroesophageal reflux patients
40. A controlled trial of metoclopramide in symptomatic gastroesophageal reflux
41. Cimetidine, metoclopramide or placebo in the treatment of symptomatic gastroesophageal reflux
42. Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis
43. Effect of domperidone in patients with symptomatic gastroesophageal reflux
44. Domperidone in the treatment of postprandial symptoms suggestive of gastroesophageal reflux
45. Comparison of ranitidine, domperidone maleate and ranitidine + domperidone maleate in the short term treatment of reflux esophagitis
46. Cisapride for gastroesophageal reflux and peptic esophagitis
47. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use as a prokinetic agent in gastrointestinal motility disorders
48. Dose-response study with cisapride in gastroesophageal reflux disease
49. Healing and prevention of relapse of reflux oesophagitis by cisapride
50. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders
51. Oral cisapride in GERD: A double-blind, placebo-controlled multicenter trial
52. Cisapride in the treatment of GERD: A double-blind, placebo-controlled multicenter dose response trial
53. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies
54. Combined therapy with cisapride and cimetidine in severe reflux oesophagitis. A double-blind controlled trial
55. Treatment of severe reflux esophagitis with cimetidine and metoclopramide
56. A comparison of five maintenance therapies for reflux esophagitis
57. Speed of healing and symptom relief in grade ii to iv gastroesophageal reflux disease: A meta-analysis
58. Gastric colonization in patients receiving antacids and medicinal modalities: A mechanism for pharyngeal colonization
59. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization
60. Clinical significance of hypergastrinemia: Relevance to gastrin monitoring during omeprazole therapy
61. Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth and gastritis
62. Effects of hypochlorhydria and hypergastrinemia on the structure and function of gastrointestinal cells. A review and analysis
63. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status
64. Rebound acid hyper-secretion after gastric acid suppressant therapy: A short lived (< 1 week) phenomenon
65. Effects of gastric acid suppressants on human gastric motility
66. Gastro-oesophageal reflux disease in adults and children
67. Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects
68. Activation of GABA(B) receptor inhibits transient lower esophageal sphincter relaxation in dogs
69. Inhibition of gastro-esophageal reflux and transient lower esophageal sphincter relaxations in ferrets by GABA(B) receptor ligands
70. The GABA(B) agonist baclofen inhibits transient lower esophageal sphincter relaxations and gastroesophageal reflux in normal human subjects
71. Involvement of cholecystokinin A receptors in transient lower esophageal sphincter relaxations triggered by gastric dissension
72. Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis
73. Tegaserod
74. 4 agonist, prucalopride in healthy humans
75. Receptor for motilin identified in the human gastrointestinal system
76. Effects of octreotide and erythromycin on gastric myoelectrical and motor activities in patients with gastroparesis
77. Gastrointestinal motor effects of erythromycin
78. Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs
79. Effect of leucine 13-motilin (KW5139) on early gastric stasis after pylorus-preserving pancreatoduodenectomy
80. Effects of trimebutine maleate on gastric motility in patients with gastric ulcer